Gastrointestinal stromal tumors: The role of the gastroenterologist in diagnosis and risk stratification

Douglas Orrick Faigel, Susan Abulhawa

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors that are best classified as sarcomas with variable aggressiveness. They are typically treated with surgical resection and adjuvant tyrosine kinase inhibitors or, for advanced/metastatic GISTs, with tyrosine kinase inhibitors alone. Gastroenterologists are often the first to detect GISTs and are, therefore, tasked with diagnosis and facilitation of early intervention. Diagnostic tools including various imaging techniques such as endoscopic ultrasound (EUS) and EUS-assisted tissue sampling are critical for an accurate diagnosis. In the case of small tumors, EUS-assisted resection or ligation techniques to treat asymptomatic small tumors have been described. This paper reviews current evidence for the diagnosis and management of GISTs, with an emphasis on the role of the gastroenterologist.

Original languageEnglish (US)
Pages (from-to)629-636
Number of pages8
JournalJournal of Clinical Gastroenterology
Volume46
Issue number8
DOIs
StatePublished - Sep 2012

Fingerprint

Gastrointestinal Stromal Tumors
Protein-Tyrosine Kinases
Neoplasms
Sarcoma
Ligation
Gastroenterologists

Keywords

  • detection
  • gastroenterologist
  • GIST

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Gastrointestinal stromal tumors : The role of the gastroenterologist in diagnosis and risk stratification. / Faigel, Douglas Orrick; Abulhawa, Susan.

In: Journal of Clinical Gastroenterology, Vol. 46, No. 8, 09.2012, p. 629-636.

Research output: Contribution to journalArticle

@article{224c0a0317ea45d1b34586caec7c1972,
title = "Gastrointestinal stromal tumors: The role of the gastroenterologist in diagnosis and risk stratification",
abstract = "Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors that are best classified as sarcomas with variable aggressiveness. They are typically treated with surgical resection and adjuvant tyrosine kinase inhibitors or, for advanced/metastatic GISTs, with tyrosine kinase inhibitors alone. Gastroenterologists are often the first to detect GISTs and are, therefore, tasked with diagnosis and facilitation of early intervention. Diagnostic tools including various imaging techniques such as endoscopic ultrasound (EUS) and EUS-assisted tissue sampling are critical for an accurate diagnosis. In the case of small tumors, EUS-assisted resection or ligation techniques to treat asymptomatic small tumors have been described. This paper reviews current evidence for the diagnosis and management of GISTs, with an emphasis on the role of the gastroenterologist.",
keywords = "detection, gastroenterologist, GIST",
author = "Faigel, {Douglas Orrick} and Susan Abulhawa",
year = "2012",
month = "9",
doi = "10.1097/MCG.0b013e3182548f6c",
language = "English (US)",
volume = "46",
pages = "629--636",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Gastrointestinal stromal tumors

T2 - The role of the gastroenterologist in diagnosis and risk stratification

AU - Faigel, Douglas Orrick

AU - Abulhawa, Susan

PY - 2012/9

Y1 - 2012/9

N2 - Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors that are best classified as sarcomas with variable aggressiveness. They are typically treated with surgical resection and adjuvant tyrosine kinase inhibitors or, for advanced/metastatic GISTs, with tyrosine kinase inhibitors alone. Gastroenterologists are often the first to detect GISTs and are, therefore, tasked with diagnosis and facilitation of early intervention. Diagnostic tools including various imaging techniques such as endoscopic ultrasound (EUS) and EUS-assisted tissue sampling are critical for an accurate diagnosis. In the case of small tumors, EUS-assisted resection or ligation techniques to treat asymptomatic small tumors have been described. This paper reviews current evidence for the diagnosis and management of GISTs, with an emphasis on the role of the gastroenterologist.

AB - Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors that are best classified as sarcomas with variable aggressiveness. They are typically treated with surgical resection and adjuvant tyrosine kinase inhibitors or, for advanced/metastatic GISTs, with tyrosine kinase inhibitors alone. Gastroenterologists are often the first to detect GISTs and are, therefore, tasked with diagnosis and facilitation of early intervention. Diagnostic tools including various imaging techniques such as endoscopic ultrasound (EUS) and EUS-assisted tissue sampling are critical for an accurate diagnosis. In the case of small tumors, EUS-assisted resection or ligation techniques to treat asymptomatic small tumors have been described. This paper reviews current evidence for the diagnosis and management of GISTs, with an emphasis on the role of the gastroenterologist.

KW - detection

KW - gastroenterologist

KW - GIST

UR - http://www.scopus.com/inward/record.url?scp=84865504761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865504761&partnerID=8YFLogxK

U2 - 10.1097/MCG.0b013e3182548f6c

DO - 10.1097/MCG.0b013e3182548f6c

M3 - Article

C2 - 22858511

AN - SCOPUS:84865504761

VL - 46

SP - 629

EP - 636

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 8

ER -